NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00712140,Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer,https://clinicaltrials.gov/study/NCT00712140,,UNKNOWN,"RATIONALE: Monoclonal antibodies, such as trastuzumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. It is not yet known which regimen of trastuzumab is more effective in treating early breast cancer.

PURPOSE: This randomized phase III trial is comparing two trastuzumab regimens to see how well they work in treating women with HER2-positive early breast cancer.",NO,Breast Cancer,BIOLOGICAL: trastuzumab|DRUG: parenteral chemotherapy,Disease-free survival,Overall survival|Cost effectiveness and quality of life|Cardiac function and analysis of predictive factors for development of cardiac damage,,Warwick Medical School,,FEMALE,"ADULT, OLDER_ADULT",PHASE3,4000,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT,CDR0000598391|WMS-PERSEPHONE|MREC-PERSEPHONE|EUDRACT: 2006-007018-39|ISRCTN 52968807|MREC 07/MRE08/35|EU-20858|CRUK-BRD/07/137,2007-10,2011-10,,2008-07-09,,2011-09-02,"Addenbrooke's Hospital, Cambridge, England, CB2 2QQ, United Kingdom|Cumberland Infirmary, Carlisle, England, CA2 7HY, United Kingdom|Derbyshire Royal Infirmary, Derby, England, DE1 2QY, United Kingdom|Eastbourne District General Hospital, Eastbourne, England, BN21 2UD, United Kingdom|Luton and Dunstable Hospital, Luton, England, LU4 0DZ, United Kingdom|Clatterbridge Centre for Oncology, Merseyside, England, CH63 4JY, United Kingdom|James Cook University Hospital, Middlesbrough, England, TS4 3BW, United Kingdom|Mount Vernon Cancer Centre at Mount Vernon Hospital, Northwood, England, HA6 2RN, United Kingdom|Peterborough Hospitals Trust, Peterborough, England, PE3 6DA, United Kingdom|New Cross Hospital, Wolverhampton, England, WV10 0QP, United Kingdom|Aberdeen Royal Infirmary, Aberdeen, Scotland, AB25 2ZN, United Kingdom",
